Previous 10 | Next 10 |
-- Further Protects Longevity of BENDEKA franchise -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) and Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) (“Teva”) announced today that on April 27, 2020, the U.S. Distric...
IND Submitted to FDA for Planned Clinical Study at Hackensack University Medical Center to Evaluate RYANODEX for Treatment of COVID-19 Patients Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”), a New Jersey-based pharmaceutical company, today announced that its product ...
Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) today announced that its marketing partner SymBio Pharmaceuticals Limited (“SymBio”) has completed patient enrollment in a clinical trial for TREAKISYM rapid infusion (“RI...
Tyme Technologies ( TYME ) had a noteworthy 2019 with several major milestones to add to the bullish case. What is more, Tyme has multiple catalysts scheduled in the first and second half of 2020, which will only add to that bullish case. Despite the recent and pending milestones, the share pr...
Eagle Pharmaceuticals, Inc. ("Eagle" or the “Company”) (Nasdaq: EGRX) today announced that the Company will release its 2019 fourth quarter and full year financial results on Monday, March 2, 2020, before the market opens. Scott Tarriff, Chief Executive Officer, and Pete Mey...
Original Post Editor's Note : The summary bullets for this article were chosen by Seeking Read more ...
-- Eagle has exclusive rights to commercialize product for four months beginning February 1, 2022 -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that it has received final approval from the U.S. Food and Drug Administr...
BlackRock Inc. ( BLK ) and Vanguard Group Inc. represent the world’s two largest Asset Management Companies. According to 2019 Q3 filing, BlackRock had $6.96 trillion USD in assets under management. While, according Vanguard , they had $5.6 trillion USD assets under management on Augus...
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”) today announced that Eagle and the University of Pennsylvania (“Penn”) have agreed on terms of a new exclusive worldwide license agreement for the development of dantrolene sodium for the potential treatment of p...
Tyme Technologies ( TYME ) is moving closer to a transformative point in the company’s history. Tyme is now working on their enrollment of two pancreatic cancer pivotal trials for SM-88. If successful, these programs will bring tremendous value to the company and their shareholders. So ...
News, Short Squeeze, Breakout and More Instantly...
Eagle Pharmaceuticals Inc. Company Name:
EGRX Stock Symbol:
NASDAQ Market:
Eagle Pharmaceuticals Inc. Website:
2024-07-27 11:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-17 12:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-07 19:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...